Search

Evusheld is an extra COVID-19 medication that provides added protection for vulnerable patients. Peter Mac is recommending this medication for patients with blood cancer, or cancer patients who are... Read more

An AI-powered, virtual platform is being developed to improve care for patients living with genetic disorders, as part of a Digital Health CRC project led by Peter MacCallum Cancer Centre and Swinburne University of... Read more

A Peter Mac-led clinical trial has found combination PET/CT scans are better at investigating the causes of prolonged fever in blood cancer patients than conventional CT scans. The randomised multicentre trial found patients... Read more

Chronic lymphocytic leukaemia (CLL) patients who are refractory or resistant to treatment can be encouraged by data showing significantly longer survival without disease progression with a treatment combining venetoclax and... Read more

Peter Mac's Associate Professor Jane Oliaro and Professor Ricky Johnstone have been awarded funding for two different blood cancer research projects. Associate Professor Oliaro will use a three year grant to make CAR T-cell... Read more

For NAIDOC Week 2022, join us on this immersive virtual tour of Peter Mac's Aboriginal art collection. The varied paintings in our collection illustrate some of the multiple strands, diversity and evolving nature of... Read more